Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

179 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner KM, Svedman C. Wersäll PJ, et al. Among authors: lax i. Acta Oncol. 2006;45(4):493-7. doi: 10.1080/02841860600604611. Acta Oncol. 2006. PMID: 16760190 No abstract available.
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, Johansson KA, Ekberg L, Morhed E, Paludan M, Wittgren L, Blomgren H, Lewensohn R. Baumann P, et al. Among authors: lax i. Acta Oncol. 2006;45(7):787-95. doi: 10.1080/02841860600904862. Acta Oncol. 2006. PMID: 16982541
Assessment of testicular dose during preoperative radiotherapy for rectal cancer.
Buchli C, Al Abani M, Ahlberg M, Holm T, Fokstuen T, Bottai M, Frödin JE, Lax I, Martling A. Buchli C, et al. Among authors: lax i. Acta Oncol. 2016;55(4):496-501. doi: 10.3109/0284186X.2015.1073349. Epub 2015 Sep 11. Acta Oncol. 2016. PMID: 26362484 Clinical Trial.
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience.
Lindberg K, Nyman J, Riesenfeld Källskog V, Hoyer M, Lund JÅ, Lax I, Wersäll P, Karlsson K, Friesland S, Lewensohn R. Lindberg K, et al. Among authors: lax i. Acta Oncol. 2015;54(8):1096-104. doi: 10.3109/0284186X.2015.1020966. Epub 2015 Mar 27. Acta Oncol. 2015. PMID: 25813471 Clinical Trial.
Survival and tumour control probability in tumours with heterogeneous oxygenation: a comparison between the linear-quadratic and the universal survival curve models for high doses.
Lindblom E, Dasu A, Lax I, Toma-Dasu I. Lindblom E, et al. Among authors: lax i. Acta Oncol. 2014 Aug;53(8):1035-40. doi: 10.3109/0284186X.2014.925582. Epub 2014 Jun 24. Acta Oncol. 2014. PMID: 24957551
The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model.
Wennberg B, Lax I. Wennberg B, et al. Among authors: lax i. Acta Oncol. 2013 Jun;52(5):902-9. doi: 10.3109/0284186X.2012.728292. Epub 2013 Jan 17. Acta Oncol. 2013. PMID: 23327339
NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Wennberg BM, Baumann P, Gagliardi G, Nyman J, Drugge N, Hoyer M, Traberg A, Nilsson K, Morhed E, Ekberg L, Wittgren L, Lund JÅ, Levin N, Sederholm C, Lewensohn R, Lax I. Wennberg BM, et al. Among authors: lax i. Acta Oncol. 2011 May;50(4):518-27. doi: 10.3109/0284186X.2010.543695. Epub 2011 Jan 4. Acta Oncol. 2011. PMID: 21198416
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Svedman C, Karlsson K, Rutkowska E, Sandström P, Blomgren H, Lax I, Wersäll P. Svedman C, et al. Among authors: lax i. Acta Oncol. 2008;47(8):1578-83. doi: 10.1080/02841860802123196. Acta Oncol. 2008. PMID: 18607859
Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions.
Lax I, Panettieri V, Wennberg B, Amor Duch M, Näslund I, Baumann P, Gagliardi G. Lax I, et al. Acta Oncol. 2006;45(7):978-88. doi: 10.1080/02841860600900050. Acta Oncol. 2006. PMID: 16982567
Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer.
Djärv E, Nyman J, Baumann P, Ekberg L, Høyer M, Lax I, Lewensohn R, Levin N, Lund JA, Morhed E, Ericsson SR, Traberg A, Wittgren L, Johansson KA. Djärv E, et al. Among authors: lax i. Acta Oncol. 2006;45(7):973-7. doi: 10.1080/02841860600919241. Acta Oncol. 2006. PMID: 16982566
179 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback